Aug 14 (Reuters)-
Cyfuse Biomedical K.K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2023 Jun 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 18 mln 332 mln 604 mln
(-94.5 pct) (+61.5 pct)
Operating loss 363 mln loss 96 mln loss 833 mln
Recurring loss 362 mln loss 76 mln loss 680 mln
Net loss 364 mln loss 114 mln loss 682 mln
EPS loss 46.73 yen loss 203.61 yen loss 87.78 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Cyfuse Biomedical K.K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T